• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Percutaneous coronary interventions with drug eluting stents for diabetic patients.

作者信息

Seabra-Gomes Ricardo

机构信息

Instituto do Coração, Lisbon, Portugal.

出版信息

Heart. 2006 Mar;92(3):410-9. doi: 10.1136/hrt.2005.062992.

DOI:10.1136/hrt.2005.062992
PMID:16501210
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1860831/
Abstract
摘要

相似文献

1
Percutaneous coronary interventions with drug eluting stents for diabetic patients.糖尿病患者使用药物洗脱支架的经皮冠状动脉介入治疗
Heart. 2006 Mar;92(3):410-9. doi: 10.1136/hrt.2005.062992.
2
Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome.药物洗脱支架冠状动脉综合血运重建：即刻及7个月结果
J Thorac Cardiovasc Surg. 2006 May;131(5):956-62. doi: 10.1016/j.jtcvs.2005.10.058. Epub 2006 Apr 27.
3
One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.药物洗脱支架植入治疗多支冠状动脉疾病的一年临床结果及总成本
J Cardiovasc Med (Hagerstown). 2007 Aug;8(8):596-601. doi: 10.2459/JCM.0b013e32801051f4.
4
Optimal revascularization strategy for diabetic patients with multivessel coronary artery disease: the duel between old hero and young warrior.多支冠状动脉疾病糖尿病患者的最佳血运重建策略：老英雄与年轻勇士的对决
Int J Cardiol. 2009 Jan 9;131(2):269-70; author reply 271-2. doi: 10.1016/j.ijcard.2007.05.103. Epub 2007 Aug 10.
5
Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.多支冠状动脉疾病患者冠状动脉搭桥术与药物洗脱支架经皮冠状动脉介入治疗的疗效比较
Circulation. 2007 Sep 11;116(11 Suppl):I200-6. doi: 10.1161/CIRCULATIONAHA.106.681148.
6
Revascularisation strategy for diabetic multivessel coronary arteriopathy.
J Indian Med Assoc. 2006 Apr;104(4):186, 188-9, 194.
7
Drug-eluting stents or drug-eluting conduits for multivessel disease?药物洗脱支架还是用于多支血管病变的药物洗脱导管？
J Cardiovasc Med (Hagerstown). 2007 May;8(5):359-61. doi: 10.2459/JCM.0b013e32807fb060.
8
Revascularization of unprotected left main coronary artery disease with percutaneous coronary intervention: the role of drug-eluting stents.经皮冠状动脉介入治疗无保护左主干冠状动脉疾病的血运重建：药物洗脱支架的作用
Minerva Cardioangiol. 2008 Feb;56(1):43-53.
9
Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.糖尿病患者与非糖尿病患者的多支冠状动脉血运重建：ARTS-II（动脉血运重建治疗研究 - 第二部分）试验的3年随访
J Am Coll Cardiol. 2008 Dec 9;52(24):1957-67. doi: 10.1016/j.jacc.2008.09.010.
10
Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease.两项关于西罗莫司洗脱支架与紫杉醇洗脱支架用于高危冠心病患者的随机试验的成本分析。
J Am Coll Cardiol. 2006 Jul 18;48(2):262-7. doi: 10.1016/j.jacc.2006.01.080. Epub 2006 Jun 22.

引用本文的文献

1
Association of plasma endothelin-1 levels with revascularization strategies and short-term clinical outcomes: Role of diabetes.血浆内皮素-1水平与血运重建策略及短期临床结局的关联：糖尿病的作用
Heliyon. 2024 Sep 11;10(18):e37777. doi: 10.1016/j.heliyon.2024.e37777. eCollection 2024 Sep 30.
2
Biofunctionalization of cardiovascular stents to induce endothelialization: Implications for in- stent thrombosis in diabetes.心血管支架的生物功能化以诱导内皮化：对糖尿病患者支架内血栓形成的影响。
Front Pharmacol. 2022 Oct 10;13:982185. doi: 10.3389/fphar.2022.982185. eCollection 2022.
3
Percutaneous coronary intervention in insulin-treated diabetic patients: A meta-analysis.经皮冠状动脉介入治疗在胰岛素治疗的糖尿病患者中的应用：一项荟萃分析。
Ann Noninvasive Electrocardiol. 2022 Sep;27(5):e12953. doi: 10.1111/anec.12953. Epub 2022 Apr 25.
4
Some Perspectives on Hypersensitivity to Coronary Stents.关于冠状动脉支架超敏反应的一些观点
Int J Gen Med. 2021 Aug 10;14:4327-4336. doi: 10.2147/IJGM.S326679. eCollection 2021.
5
Long-term outcomes of medical therapy versus successful recanalisation for coronary chronic total occlusions in patients with and without type 2 diabetes mellitus.比较有/无 2 型糖尿病的冠状动脉慢性完全闭塞患者药物治疗与血运重建成功后长期预后。
Cardiovasc Diabetol. 2020 Jul 4;19(1):100. doi: 10.1186/s12933-020-01087-4.
6
In-Hospital Outcome of Patients with Diabetes Mellitus after CTO Recanalization with Third-Generation Drug-Eluting Stents.糖尿病患者经第三代药物洗脱支架进行慢性完全闭塞病变再通后的院内结局
J Tehran Heart Cent. 2019 Apr;14(2):47-52.
7
Liraglutide Inhibits Endothelial-to-Mesenchymal Transition and Attenuates Neointima Formation after Endovascular Injury in Streptozotocin-Induced Diabetic Mice.利拉鲁肽抑制链脲佐菌素诱导的糖尿病小鼠血管内损伤后内皮向间充质转化并减轻新生内膜形成。
Cells. 2019 Jun 14;8(6):589. doi: 10.3390/cells8060589.
8
Comparison of clinical outcomes after drug-eluting stent implantation in diabetic versus nondiabetic patients in China: A retrospective study.中国糖尿病患者与非糖尿病患者药物洗脱支架植入术后临床结局的比较：一项回顾性研究。
Medicine (Baltimore). 2017 Apr;96(17):e6647. doi: 10.1097/MD.0000000000006647.
9
Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.新型肽WKYMVm与西罗莫司涂层支架对再内皮化和抗再狭窄的影响
J Mater Sci Mater Med. 2015 Oct;26(10):251. doi: 10.1007/s10856-015-5585-1. Epub 2015 Oct 5.
10
Favorable Outcomes after Implantation of Biodegradable Polymer Coated Sirolimus-Eluting Stents in Diabetic Population: Results from INDOLIMUS-G Diabetic Registry.糖尿病患者植入可生物降解聚合物涂层西罗莫司洗脱支架后的良好预后：INDOLIMUS-G糖尿病注册研究结果
Int J Vasc Med. 2015;2015:265670. doi: 10.1155/2015/265670. Epub 2015 Sep 2.

本文引用的文献

1
Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.西罗莫司洗脱支架与标准支架用于糖尿病患者经皮冠状动脉血运重建的随机对照研究：糖尿病与西罗莫司洗脱支架（DIABETES）试验
Circulation. 2005 Oct 4;112(14):2175-83. doi: 10.1161/CIRCULATIONAHA.105.562421.
2
Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials.冠心病患者中雷帕霉素洗脱支架与紫杉醇洗脱支架的比较：随机试验的荟萃分析
JAMA. 2005 Aug 17;294(7):819-25. doi: 10.1001/jama.294.7.819.
3
Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.紫杉醇洗脱支架或西罗莫司洗脱支架预防糖尿病患者再狭窄
N Engl J Med. 2005 Aug 18;353(7):663-70. doi: 10.1056/NEJMoa044372. Epub 2005 Aug 16.
4
Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial.冠状动脉支架置入术与冠状动脉搭桥术治疗多支血管病变的五年疗效：动脉血运重建治疗研究（ARTS）随机试验的最终分析
J Am Coll Cardiol. 2005 Aug 16;46(4):575-81. doi: 10.1016/j.jacc.2004.12.082.
5
Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries).293例连续糖尿病患者（来自RESEARCH和T-SEARCH注册研究）中，西罗莫司洗脱支架与紫杉醇洗脱支架短期（1个月）和长期（12个月）疗效的比较
Am J Cardiol. 2005 Aug 1;96(3):358-62. doi: 10.1016/j.amjcard.2005.03.075.
6
Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison.药物洗脱支架比较中的管腔直径晚期丢失和二元再狭窄。
Circulation. 2005 Jun 28;111(25):3435-42. doi: 10.1161/CIRCULATIONAHA.104.513952. Epub 2005 Jun 20.
7
Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study.吡格列酮可独立于血糖控制降低2型糖尿病患者的颈动脉内膜中层厚度：一项对照随机研究的结果
Circulation. 2005 May 17;111(19):2525-31. doi: 10.1161/01.CIR.0000165072.01672.21. Epub 2005 May 9.
8
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.药物洗脱支架成功植入后血栓形成的发生率、预测因素及转归
JAMA. 2005 May 4;293(17):2126-30. doi: 10.1001/jama.293.17.2126.
9
Molecular basis of restenosis and drug-eluting stents.再狭窄与药物洗脱支架的分子基础
Circulation. 2005 May 3;111(17):2257-73. doi: 10.1161/01.CIR.0000163587.36485.A7.
10
Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus.胰岛素抵抗、糖耐量受损及2型糖尿病中的冠状动脉循环功能障碍。
Circulation. 2005 May 10;111(18):2291-8. doi: 10.1161/01.CIR.0000164232.62768.51. Epub 2005 Apr 25.